You just read:

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™

News provided by

AbbVie

Apr 12, 2014, 01:00 ET